Genelux (GNLX) Retained Earnings (2022 - 2026)
Genelux (GNLX) recorded quarterly Retained Earnings of -$292.5 million in Q1 2026, down 3.15% quarter-over-quarter from -$283.5 million in Q4 2025.
Genelux (GNLX) Retained Earnings (2022 - 2026) Analysis & Trends
Genelux's Retained Earnings history runs 5 years deep, the most recent figure standing at -$292.5 million for Q1 2026.
- In Q1 2026, Retained Earnings changed N/A year-over-year to -$292.5 million; the TTM figure through Mar 2026 stood at -$292.5 million (changed N/A YoY), while the FY2025 annual figure was -$283.5 million, down 443128.12% from the prior year.
- Retained Earnings was -$292.5 million for Q1 2026 at Genelux, down from -$283.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $64000.0 in Q4 2024 to a low of -$292.5 million in Q1 2026.
- Historically, Retained Earnings has averaged -$157.6 million across 5 years, with a median of -$221.5 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 12120950.0% in 2024, then surged 127.27% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$189.8 million in 2022, then slipped by 16.72% to -$221.5 million in 2023, then jumped by 100.03% to $64000.0 in 2024, then slumped by 443128.12% to -$283.5 million in 2025, then fell by 3.15% to -$292.5 million in 2026.
- The last three Retained Earnings figures came in at -$292.5 million (Q1 2026), -$283.5 million (Q4 2025), and -$274.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -292.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -292.47 Mn |
| Dec 31, 2025 | -283.54 Mn |
| Sep 30, 2025 | -274.29 Mn |
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -242.42 Mn |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -229.37 Mn |
| Dec 31, 2023 | -221.52 Mn |
| Sep 30, 2023 | 2,000.00 |
| Dec 31, 2022 | -189.78 Mn |